Drugs to delay preterm birth are safe for global reduction in neonatal death

Women around the world should be able to access the best drug treatments that help to delay preterm births and improve outcomes for newborns, suggests new research. Researchers from BHP founder-member the University of Birmingham worked with colleagues from the World Health Organization to review 122 randomised trials – published between 1966 and 2021, involving … Continue reading “Drugs to delay preterm birth are safe for global reduction in neonatal death”

Preventative COVID-19 treatment to be trialled in Birmingham

A drug trial that could prevent the most vulnerable people from catching COVID-19, particularly people for whom vaccines are less effective, has begun in Birmingham. The trial will test the effectiveness of Sotrovimab, a drug which has shown promising results for treating COVID-19, in people at high risk for disease progression. (Gupta et al (2021) … Continue reading “Preventative COVID-19 treatment to be trialled in Birmingham”

Professor Peter Brocklehurst responds to the Women’s Health Strategy

The Chair of the Birmingham Health Partners Commission which led the Healthy Mum, Healthy Baby, Healthy Future report has welcomed the first ever Women’s Health Strategy for England to tackle the gender health gap. The commission set out a raft of recommendations for the UK to lead the development of safe, effective and accessible medicines … Continue reading “Professor Peter Brocklehurst responds to the Women’s Health Strategy”

Study finds raised levels of autoantibodies affecting the heart after severe COVID-19

A new UK Coronavirus Immunology Consortium study led by researchers from BHP founder-member the University of Birmingham, suggests that severe COVID-19 infections may trigger an autoimmune response against the heart. Heart problems are one of a number of recognised complications of COVID-19, but the biological mechanism underpinning this link remains unclear. One theory is that COVID-19 infection … Continue reading “Study finds raised levels of autoantibodies affecting the heart after severe COVID-19”

Investigational drug fosters nerve repair after injury

Scientists from BHP founder-members the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma. The research, published today in Clinical and Translational Medicine, used cell and animal models to demonstrate that when taken orally the candidate drug, known as AZD1390, can … Continue reading “Investigational drug fosters nerve repair after injury”